Completed OBSERVATIONAL NCT02153242

The Effects of Selective Site Right Ventricular Pacing (PacingRV)

Does a Surrogate Marker Exist That Can be Used as A Predictor For Left Ventricular Dysfunction In Patients Undergoing Right Ventricular Pacing

Sponsor: Mid and South Essex NHS Foundation Trust

Conditions Bradycardia

Updated 6 times since 2017 Last updated: Dec 21, 2020 Started: Sep 30, 2013 Primary completion: Jun 30, 2015 Completion: Jun 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Bradycardia, this trial is completed. The trial is conducted by Mid and South Essex NHS Foundation Trust and has accumulated 6 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Sep 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mid and South Essex NHS Foundation Trust

Data source: Mid and South Essex NHS Foundation Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Basildon, United Kingdom